User profiles for V. K. Kozyreva
 | Varvara KozyrevaCalifornia Department of Public Health Verified email at cdph.ca.gov Cited by 544 |
Validation and implementation of clinical laboratory improvements act-compliant whole-genome sequencing in the public health microbiology laboratory
VK Kozyreva, CL Truong, AL Greninger… - Journal of clinical …, 2017 - Am Soc Microbiol
Public health microbiology laboratories (PHLs) are on the cusp of unprecedented improvements
in pathogen identification, antibiotic resistance detection, and outbreak investigation by …
in pathogen identification, antibiotic resistance detection, and outbreak investigation by …
Recent outbreaks of shigellosis in California caused by two distinct populations of Shigella sonnei with either increased virulence or fluoroquinolone resistance
Shigella sonnei has caused unusually large outbreaks of shigellosis in California in 2014 and
2015. Preliminary data indicated the involvement of two distinct bacterial populations, one …
2015. Preliminary data indicated the involvement of two distinct bacterial populations, one …
Dual targeting of mesenchymal and amoeboid motility hinders metastatic behavior
…, YV Loskutov, KM Marinak, VK Kozyreva… - Molecular Cancer …, 2017 - AACR
Commonly upregulated in human cancers, the scaffolding protein NEDD9/HEF1 is a known
regulator of mesenchymal migration and cancer cell plasticity. However, the functional role …
regulator of mesenchymal migration and cancer cell plasticity. However, the functional role …
NEDD9/Arf6-dependent endocytic trafficking of matrix metalloproteinase 14: a novel mechanism for blocking mesenchymal cell invasion and metastasis of breast …
YV Loskutov, PY Kozyulina, VK Kozyreva, RJ Ice… - Oncogene, 2015 - nature.com
NEDD9 is an established marker of invasive and metastatic cancers. NEDD9 downregulation
has been shown to dramatically reduce cell invasion and metastasis in multiple tumors. …
has been shown to dramatically reduce cell invasion and metastasis in multiple tumors. …
NEDD9 regulates actin dynamics through cortactin deacetylation in an AURKA/HDAC6–dependent manner
VK Kozyreva, SL McLaughlin, RH Livengood… - Molecular Cancer …, 2014 - AACR
The prometastatic protein NEDD9 (neural precursor cell expressed, developmentally
downregulated 9) is highly expressed in many cancers and is required for mesenchymal individual …
downregulated 9) is highly expressed in many cancers and is required for mesenchymal individual …
[HTML][HTML] Laboratory Investigation of Salmonella enterica serovar Poona Outbreak in California: Comparison of Pulsed-Field Gel Electrophoresis (PFGE) and Whole …
VK Kozyreva, J Crandall, A Sabol, A Poe, P Zhang… - PLoS …, 2016 - ncbi.nlm.nih.gov
Methods: CA Salmonella Poona isolates, collected from July to August 2015, were genotyped
by PFGE using XbaI restriction enzyme. WGS was done using Nextera XT library kit with …
by PFGE using XbaI restriction enzyme. WGS was done using Nextera XT library kit with …
Combination of eribulin and Aurora A inhibitor MLN8237 prevents metastatic colonization and induces cytotoxic autophagy in breast cancer
… VK Kozyreva and AA Kiseleva contributed equally to this article. … Writing, review, and/or
revision of the manuscript: VK Kozyreva, RJ Ice, K. Marinak, RH Livengood, MA Salkeni, S. Wen, …
revision of the manuscript: VK Kozyreva, RJ Ice, K. Marinak, RH Livengood, MA Salkeni, S. Wen, …
NEDD9 depletion leads to MMP14 inactivation by TIMP2 and prevents invasion and metastasis
…, PY Kozyulina, RH Livengood, VK Kozyreva… - Molecular Cancer …, 2014 - AACR
The scaffolding protein NEDD9 is an established prometastatic marker in several cancers.
Nevertheless, the molecular mechanisms of NEDD9-driven metastasis in cancers remain ill-…
Nevertheless, the molecular mechanisms of NEDD9-driven metastasis in cancers remain ill-…
Bacterial Resistance Studies Using In Vitro Dynamic Models: the Predictive Power of the Mutant Prevention and Minimum Inhibitory Antibiotic Concentrations
…, DS Shlykova, YA Portnoy, VK Kozyreva… - Antimicrobial agents …, 2013 - Am Soc Microbiol
In light of the concept of the mutant selection window, ie, the range between the MIC and the
mutant prevention concentration (MPC), MPC-related pharmacokinetic indices should be …
mutant prevention concentration (MPC), MPC-related pharmacokinetic indices should be …
[HTML][HTML] First detection of VIM-4 metallo-β-lactamase-producing Escherichia coli in Russia
…, DY Mudrak, EY Skleenova, VK Kozyreva… - Clinical Microbiology …, 2012 - Elsevier
An Escherichia coli isolate co-producing VIM-4 metallo-β-lactamase and CTX-M-15 extended
spectrum β-lactamase was recovered from the urine of a patient with head trauma in …
spectrum β-lactamase was recovered from the urine of a patient with head trauma in …